Eyal C. Attar

APRE

Eyal C. Attar serves as SVP, Chief Medical Officer at Aprea Therapeutics, Inc. (APRE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$199.3K

Net Position

Net Seller

$199.3K

Companies Traded

APRE

Active Period

Aug 2021 – Jun 2022

4 total trades

Most Recent

Sell APRE

Jun 3, 2022 · $26.3K

Eyal C. Attar's Insider Trading at Aprea Therapeutics, Inc. (APRE)

Buys

0 · $0.00

Sells

4 · $199.3K

Total Shares Bought

Total Shares Sold

93,667

APRE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Jun 3, 2022↗	Sell	32,667	$0.80	$26.3K
Feb 28, 2022↗	Sell	36,000	$1.73	$62.3K
Sep 16, 2021↗	Sell	15,968	$4.68	$74.7K
Aug 25, 2021↗	Sell	9,032	$3.98	$35.9K

Related Insiders

Oren Gilad

President/CEO

APREBuy · Jan 30, 2026

John P. Hamill

officer: SrVP/CFO/Prin Fin & Acct Ofcr

APREBuy · Jan 30, 2026

John P. Hamill

SrVP/CFO/Prin Fin & Acct Ofcr

APREBuy · Jan 30, 2026

Marc Duey

Director

APREBuy · Dec 10, 2025

Explore More Insider Trading Data

APRE Insider Trading Activity

View all insider trades at Aprea Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity